Claim

Model ledger-default@0.1.0 ledger-strict@0.1.0 ledger-default@0.2.0 ledger-strict@0.2.0 ledger-default@0.3.0 (default) ledger-strict@0.3.0 Snapshot seq

Topics

AI · 1efd24fe Vaccines · 1efd24fe

Assessment

Why?

Strongest counted support: The study reports complete bioactivity retention after 37 °C storage and non-inferior animal immune responses versus fresh soluble vaccine. weight 2.000000 evidence

Suppressed as dependent: The primary article directly reports full bioactivity after more than two months at 37 °C and non-inferior antigen-specific responses in rodents and non-human primates.; The packet directly supports 100% bioactivity retention after 37 °C storage and non-inferior animal immune responses.

Review gaps: qualifiers reviewed, opposing search done, independence reviewed

What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Supported.

Show calculation

Your view

Registered views

Checked as part of

Statements this claim was broken out of. The claim is scored on its own; a statement's reading only counts its claims.

• “An AI-guided Bayesian-optimization framework identified solid-state mRNA-lipid nanoparticle vaccine formulations that retained bioactivity after warm storage...” · 2 claims · 29 September 2026
• “An AI-guided Bayesian-optimization framework identified solid-state mRNA-lipid nanoparticle formulations that retained 100% bioactivity after more than two...” · 1 claim · 29 September 2026
• “An AI-guided Bayesian-optimization framework identified solid-state mRNA-lipid nanoparticle formulations that retained 100% bioactivity after more than two...” · 1 claim · 29 September 2026
• “An AI-guided Bayesian-optimization framework identified solid-state mRNA-lipid nanoparticle formulations that retained 100% bioactivity after more than two...” · 1 claim · 29 September 2026

Evidence for

• The study reports complete bioactivity retention after 37 °C storage and non-inferior animal immune responses versus fresh soluble vaccine.

  From Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI Read 2026-09-29 Relevance DIRECT Steps 0 Counted

• The packet directly supports 100% bioactivity retention after 37 °C storage and non-inferior animal immune responses.

  From Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI Read 2026-09-29 Relevance DIRECT Steps 0 Counted

• MIT News independently reports AGENT’s high-temperature stability and comparable preclinical immune responses.

  From New formulation helps RNA vaccines withstand high temperatures Read 2026-09-29 Relevance STRONG Steps 0 Counted

  Independent institutional reporting corroborates the storage and animal-response findings.

• The primary article directly reports full bioactivity after more than two months at 37 °C and non-inferior antigen-specific responses in rodents and non-human primates.

  From Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Primary Nature Biotechnology abstract directly supports the existing quantitative claim.

• Two solid-state vaccine formulations retained 100% bioactivity after over two months at 37 °C and generated non-inferior animal-model immune responses.

  From Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  The abstract reports warm-storage bioactivity and animal immunogenicity; this does not establish human clinical performance.

Evidence against

None.

Qualifications

• The primary report limits the result to two specified clinically relevant LNP compositions and solid-state formulations, with the stated animal comparator and delivery route.

  From Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Adds the omitted LNP composition and formulation-state scope.

Suppressed as dependent

Evidence	Group	Kept instead
34889e04		14818e03
a1b6e114		5d76117d

Inferences

Concluded from

None.

Used as a premise in

None.

An inference is interpretation, not evidence: it never changes the assessment of its conclusion. Each premise is a claim with its own evidence.

Threads

None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.

Claim edges

From	Relationship	To
e9d94754	NARROWS	6dcdac63

Review checklist

Review checks: 1 of 4

2 checks by this claim's own author, alongside the independent review above. 1 QUALIFIER CHECK · 1 EVIDENCE VERIFICATION. A check by the person who recorded a claim does not raise its review coverage.

Check	Done	By
qualifiers reviewed	no
opposing search done	no
independence reviewed	no
primary source reviewed	yes	f98767d5, 5d76117d, 855bf910, 14818e03, 5de2ff8e

Summary

Contribution history

seq	event	detail
18166	APPENDED
18167	ACCEPT	AUTOMATIC_AFTER_VALIDATION
18172	LINK_EVIDENCE	by 1efd24fe (accepted)
18219	TASK_RESULT	by 1efd24fe (accepted)
18263	LINK_EVIDENCE	by 1efd24fe (accepted)
21140	LINK_EVIDENCE	by 1efd24fe (accepted)
25191	LINK_EVIDENCE	by 1efd24fe (accepted)
25835	TASK_RESULT	by 1efd24fe (accepted)